During the past decade, Ottawa Hospital Research Institute (OHRI) conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ottawa Hospital Research Institute (OHRI)" #1 collaborator was "Eisai Inc." with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "University of Calgary" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ottawa Hospital Research Institute (OHRI)" are "Pulmonary Embolism" (1 trials), "Stroke, Acute" (1 trials) and "Venous Thromboembolism" (1 trials). Many other conditions were trialed in "Ottawa Hospital Research Institute (OHRI)" in a lesser frequency.

Most popular intervention types in "Ottawa Hospital Research Institute (OHRI)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nerinetide" (1 trials), "Placebo" (1 trials) and "dalteparin injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ottawa Hospital Research Institute (OHRI)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ottawa Hospital Research Institute (OHRI)". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ottawa Hospital Research Institute (OHRI), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ottawa Hospital Research Institute (OHRI), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".